2013
Effect of systematic ergonomic hazard identification and control implementation on musculoskeletal disorder and injury risk.
Cantley LF, Taiwo OA, Galusha D, Barbour R, Slade MD, Tessier-Sherman B, Cullen MR. Effect of systematic ergonomic hazard identification and control implementation on musculoskeletal disorder and injury risk. Scandinavian Journal Of Work, Environment & Health 2013, 40: 57-65. PMID: 24142048, PMCID: PMC4096997, DOI: 10.5271/sjweh.3394.Peer-Reviewed Original ResearchConceptsMusculoskeletal disordersRelative riskInjury riskErgonomic hazardsHC groupRisk reductionInjury risk reductionInjury historyWorker injury riskInjury outcomesStudy periodRiskControl initiativesDisordersParticipatory ergonomicsGroupHazard identificationTemporal trendsErgonomic standardsInjuryPersonsSeroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.
Akselrod H, Grau LE, Barbour R, Heimer R. Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. American Journal Of Public Health 2013, 104: 1713-21. PMID: 24134382, PMCID: PMC3990658, DOI: 10.2105/ajph.2013.301357.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis B virusDrug use durationSubstance abuse treatmentB virusRisk factorsCriminal justice involvementDrug usersAbuse treatmentAdult injection drug usersSeroprevalence of HIVInjection drug usePotential risk factorsSignificant predictorsUse durationMultiple viral infectionsEffective harm reduction strategiesHarm reduction strategiesJustice involvementHCV seroprevalenceInjection useInterim analysisViral infectionDrug useSerological tests
2012
Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa
Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH. Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. PLOS ONE 2012, 7: e31786. PMID: 22412840, PMCID: PMC3295798, DOI: 10.1371/journal.pone.0031786.Peer-Reviewed Original ResearchConceptsXDR-TB patientsDrug-resistant tuberculosisRetrospective case-control studyXDR-TB casesCommunity-based hospitalCase-control studyGlobal public healthHIV coinfectionMicrobiological correlatesModifiable factorsAvailable interventionsRural South AfricaControl studyPatientsTuberculosisPublic healthSurvivorsSurvivalDaysHospitalMortality
2010
Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic
Niccolai LM, Verevochkin SV, Toussova OV, White E, Barbour R, Kozlov AP, Heimer R. Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. European Journal Of Public Health 2010, 21: 613-619. PMID: 20798184, PMCID: PMC3180633, DOI: 10.1093/eurpub/ckq115.Peer-Reviewed Original ResearchConceptsInjection drug usersRetrospective cohort analysisHIV incidenceEnzyme immunoassayHIV epidemicCohort analysisDrug usersBED capture enzyme immunoassayHIV incident casesRecent HIV incidenceHigh HIV incidenceHIV prevention interventionsCross-sectional studyCapture enzyme immunoassayIncident infectionsIncident casesEstimate incidenceIndependent correlatesIncidence rateIncidence estimatesPrevention interventionsCurrent epidemic situationIncidenceVulnerable populationsLow specificity
2009
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virusRespondent-driven samplingPrevalent infectionMajority of IDUsHepatitis C virus infectionSustained virological responseC virus infectionRespondent-driven sampleAssociation of genotypesIDU communityVirological responseHCV infectionAntiviral therapyC virusGenotype 3aDrug injectionVirus infectionDrug injectorsBlood samplesHCV sequencesDrug usersEndemic infectionInfectionMolecular epidemiology